You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable

  • Technology appraisal guidance
  • Reference number: TA763
  • Published:  02 February 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Resource impact
  2. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact report (PDF 248 KB)

    Published:
    02 February 2022
  • Resource impact template (Excel 1.32 MB)

    Published:
    02 February 2022

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance